'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England
- PMID: 37173697
- PMCID: PMC10182620
- DOI: 10.1186/s12954-023-00785-y
'This is hardcore': a qualitative study exploring service users' experiences of Heroin-Assisted Treatment (HAT) in Middlesbrough, England
Abstract
Background: Heroin-Assisted Treatment (HAT) is well evidenced internationally to improve health and social outcomes for people dependent on opioids who have not been helped by traditional treatment options. Despite this evidence base, England has been slow to implement HAT. The first service outside of a trial setting opened in 2019, providing twice-daily supervised injections of medical-grade heroin (diamorphine) to a select sample of high-risk heroin users in Middlesbrough. This paper explores their experiences, including the negotiation of the strict regularly controls required of a novel intervention in the UK context.
Methods: We conducted in-depth interviews with service providers and users of the Middlesbrough HAT service between September and November 2021. Data from each group were thematically analysed and reported separately. This paper details the experiences of the twelve heroin dependent men and women accessing HAT.
Results: Participants' accounts of HAT treatment evidenced a tension between the regulatory constraints and uncertainty of treatment provision, and the positive outcomes experienced through supportive service provision and an injectable treatment option. Limited confidence was held in treatment efficacy, longevity of funding, and personal capacity for treatment success. This was counteracted by a strong motivation to cease engagement with the illicit drug market. While attendance requirements placed restrictions on daily activities, participants also experienced benefits from strong, supportive bonds built with the service providers through their continued engagement.
Conclusions: The Middlesbrough HAT programme provided benefits to a high-risk population of opioid dependent people who were unable or disinclined to participate in conventional opioid substitution treatments. The findings in this paper highlight the potential for service modifications to further enhance engagement. The closure of this programme in 2022 prohibits this opportunity for the Middlesbrough community, but holds potential to inform advocacy and innovation for future HAT interventions in England.
Keywords: Harm reduction; Heroin-Assisted Treatment; Injectable opioid therapy; Opioid dependency; People who inject drugs; Recovery.
© 2023. The Author(s).
Conflict of interest statement
Daniel Ahmed (DA) works as clinical lead for Foundations Medical Practice which delivers HAT in Middlesbrough. DA was not part in the development of interview schedules, data collection, or analysis but contributed to reviewing final manuscript for context. DA was interviewed as part of the research to gather his perspectives as a practitioner by an external member of the research team so not to introduce bias during the interview process. This interview does not form part of the data used within the analysis presented in this paper.
Similar articles
-
More than just 'free heroin': Caring whilst navigating constraint in the delivery of diamorphine assisted treatment.Int J Drug Policy. 2023 Jun;116:104025. doi: 10.1016/j.drugpo.2023.104025. Epub 2023 Apr 14. Int J Drug Policy. 2023. PMID: 37062231
-
Co-located Heroin Assisted Treatment within primary care: A preliminary analysis of the implications for healthcare access, cost, and treatment delivery in the UK.Int J Drug Policy. 2024 Apr;126:104367. doi: 10.1016/j.drugpo.2024.104367. Epub 2024 Mar 8. Int J Drug Policy. 2024. PMID: 38460217
-
"It's a delicate balance": clinicians' experiences of providing heroin-assisted treatment.Harm Reduct J. 2024 Dec 31;21(1):230. doi: 10.1186/s12954-024-01135-2. Harm Reduct J. 2024. PMID: 39741328 Free PMC article.
-
Heroin-assisted treatment (HAT) a decade later: a brief update on science and politics.J Urban Health. 2007 Jul;84(4):552-62. doi: 10.1007/s11524-007-9198-y. J Urban Health. 2007. PMID: 17562183 Free PMC article. Review.
-
Does heroin-assisted treatment reduce crime? A review of randomized-controlled trials.Addiction. 2022 Mar;117(3):518-531. doi: 10.1111/add.15601. Epub 2021 Jun 22. Addiction. 2022. PMID: 34105206 Review.
Cited by
-
Barriers and facilitators to injectable opioid agonist treatment engagement within a structural vulnerability context: a qualitative study of patient experiences in Vancouver, Canada.Harm Reduct J. 2025 Jul 4;22(1):116. doi: 10.1186/s12954-025-01262-4. Harm Reduct J. 2025. PMID: 40615907 Free PMC article.
-
Health-related quality of life measures as predictors for recurrent hospitalization and mortality among patients in heroin-assisted treatment.Qual Life Res. 2025 Jul 16. doi: 10.1007/s11136-025-04019-5. Online ahead of print. Qual Life Res. 2025. PMID: 40668483 No abstract available.
-
Challenges for the implementation of injectable opioid agonist treatment: a scoping review.Harm Reduct J. 2024 Dec 4;21(1):217. doi: 10.1186/s12954-024-01102-x. Harm Reduct J. 2024. PMID: 39633369 Free PMC article.
-
Supervised on-site dosing in injectable opioid agonist treatment-considering the patient perspective. Findings from a cross-sectional interview study in two German cities.Harm Reduct J. 2023 Nov 1;20(1):162. doi: 10.1186/s12954-023-00896-6. Harm Reduct J. 2023. PMID: 37915058 Free PMC article.
-
Shaping and shifting schemas on supervised injectable opioid treatment: findings from a cross-sectional qualitative study in two German treatment facilities.Addict Sci Clin Pract. 2024 May 27;19(1):45. doi: 10.1186/s13722-024-00475-5. Addict Sci Clin Pract. 2024. PMID: 38802962 Free PMC article.
References
-
- Public Health England. United Kingdom drug situation 2019: Focal Point annual report. 2021 [cited 2022 Nov 24]. Available from: https://www.gov.uk/government/publications/united-kingdom-drug-situation...
-
- European Monitoring Centre for Drugs and Drug Addiction (EMCDDA). Drug-related deaths and mortality in Europe. 2019 [cited 2022 Nov 24]. Available from: https://www.emcdda.europa.eu/system/files/publications/11485/20193286_TD...
-
- Office for National Statistics (ONS). Deaths related to drug poisoning in England and Wales: 2020 registrations. 2020 2021 [cited 2022 Nov 24]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarri...
-
- Poulter HL, Moore H, Crow R, Ahmed D, Walker T. Diamorphine assisted treatment in Middlesbrough: a UK drug treatment case study. J Subst Use. 2022;14:1–7. doi: 10.1080/14659891.2022.2120433. - DOI
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical